Please try another search
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely...
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1055 | 1009 | 1086 | 961 | 874 | 935 |
Fund Return | 5.46% | 0.91% | 8.63% | -1.32% | -2.66% | -0.67% |
Place in category | 64 | 64 | 51 | 69 | 97 | 50 |
% in Category | 57 | 55 | 45 | 67 | 100 | 97 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MUKAM eMAXIS Slim US Equity S&P 500 | 6,349.74B | 34.65 | 21.05 | - | ||
MUKAM eMAXIS Slim All World Equity | 4,983.45B | 27.21 | 17.55 | - | ||
Slim Developed Countries Eq Index | 877.05B | 29.51 | 19.08 | - | ||
Slim All World Equity ex Japan | 629.81B | 27.84 | 17.77 | - | ||
MUKAM Morgan Stanley Global Premium | 365.91B | 17.42 | 13.15 | 11.48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet Multi-Asset Allocation Fund | 199.31B | 4.79 | -0.01 | 1.71 | ||
AMOne Global Open B Div 4Y UnHedged | 58.12B | 11.22 | 10.23 | 7.21 | ||
Capital EM F USD Short/JPY Long | 48.76B | -0.70 | -4.41 | - | ||
Nissay DC Nissay Stable Pursue | 42.18B | -1.43 | -1.84 | -0.50 | ||
Pictet Asset Allocation Div 1 Month | 38.18B | 12.06 | 3.38 | 2.87 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Dynamic Multi Asset Plus Fund(JPY) | - | 99.10 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Neutral | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review